JPY 415.0
(-0.72%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 3.83 Billion JPY | 21.18% |
2022 | 3.16 Billion JPY | -17.89% |
2021 | 3.85 Billion JPY | 12.34% |
2020 | 3.42 Billion JPY | 112.32% |
2019 | 1.61 Billion JPY | 13.1% |
2018 | 1.42 Billion JPY | -54.85% |
2017 | 3.16 Billion JPY | 49.69% |
2016 | 2.11 Billion JPY | -44.14% |
2015 | 3.78 Billion JPY | 43.22% |
2014 | 2.64 Billion JPY | 26.3% |
2013 | 2.09 Billion JPY | 2.18% |
2012 | 2.04 Billion JPY | 0.0% |
2011 | - JPY | -100.0% |
2010 | 1.52 Billion JPY | 6.14% |
2009 | 1.44 Billion JPY | 24.81% |
2008 | 1.15 Billion JPY | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | 468 Million JPY | -38.66% |
2023 FY | 3.83 Billion JPY | 21.18% |
2023 Q4 | 763 Million JPY | -43.77% |
2023 Q3 | 1.35 Billion JPY | 7.61% |
2023 Q2 | 1.26 Billion JPY | 179.6% |
2023 Q1 | 451 Million JPY | -44.93% |
2022 Q3 | 1.24 Billion JPY | 65.78% |
2022 Q4 | 819 Million JPY | -34.22% |
2022 Q1 | 348 Million JPY | -68.25% |
2022 Q2 | 751 Million JPY | 115.8% |
2022 FY | 3.16 Billion JPY | -17.89% |
2021 Q4 | 1.09 Billion JPY | -8.74% |
2021 Q3 | 1.2 Billion JPY | 0.5% |
2021 FY | 3.85 Billion JPY | 12.34% |
2021 Q1 | 667 Million JPY | 1.68% |
2021 Q2 | 1.19 Billion JPY | 79.16% |
2020 Q2 | 1.41 Billion JPY | 2421.31% |
2020 Q3 | 1.41 Billion JPY | 0.14% |
2020 Q4 | 656 Million JPY | -53.74% |
2020 FY | 3.42 Billion JPY | 112.32% |
2020 Q1 | -61 Million JPY | -115.76% |
2019 Q2 | 462 Million JPY | 38.32% |
2019 FY | 1.61 Billion JPY | 13.1% |
2019 Q4 | 387 Million JPY | -10.42% |
2019 Q3 | 432 Million JPY | -6.49% |
2019 Q1 | 334 Million JPY | -13.92% |
2018 Q4 | 388 Million JPY | -31.21% |
2018 Q1 | 212 Million JPY | -75.77% |
2018 FY | 1.42 Billion JPY | -54.85% |
2018 Q2 | 264 Million JPY | 24.53% |
2018 Q3 | 564 Million JPY | 113.64% |
2017 Q3 | 1.01 Billion JPY | 49.78% |
2017 FY | 3.16 Billion JPY | 49.69% |
2017 Q2 | 679 Million JPY | 14.7% |
2017 Q1 | 592 Million JPY | -30.11% |
2017 Q4 | 875 Million JPY | -13.96% |
2016 Q4 | 847 Million JPY | 18.13% |
2016 Q1 | 212 Million JPY | -80.24% |
2016 FY | 2.11 Billion JPY | -44.14% |
2016 Q2 | 337 Million JPY | 58.96% |
2016 Q3 | 717 Million JPY | 112.76% |
2015 Q3 | 958 Million JPY | 12.71% |
2015 FY | 3.78 Billion JPY | 43.22% |
2015 Q2 | 850 Million JPY | -5.76% |
2015 Q4 | 1.07 Billion JPY | 12.0% |
2015 Q1 | 902 Million JPY | 5.11% |
2014 Q3 | 894.43 Million JPY | 43.19% |
2014 Q2 | 624.65 Million JPY | 136.48% |
2014 Q1 | 264.14 Million JPY | 254.63% |
2014 FY | 2.64 Billion JPY | 26.3% |
2014 Q4 | 858.16 Million JPY | -4.06% |
2013 Q3 | 809.73 Million JPY | 40.47% |
2013 Q4 | 74.48 Million JPY | -90.8% |
2013 Q1 | 630.64 Million JPY | 10.54% |
2013 Q2 | 576.45 Million JPY | -8.59% |
2013 FY | 2.09 Billion JPY | 2.18% |
2012 Q1 | 330.43 Million JPY | 0.0% |
2012 Q3 | 752.33 Million JPY | 91.27% |
2012 FY | 2.04 Billion JPY | 0.0% |
2012 Q4 | 570.49 Million JPY | -24.17% |
2012 Q2 | 393.34 Million JPY | 19.04% |
2011 Q3 | 787.64 Million JPY | 53.65% |
2011 Q2 | 512.62 Million JPY | -10.61% |
2011 Q1 | 573.44 Million JPY | -4.74% |
2011 FY | - JPY | -100.0% |
2011 Q4 | - JPY | -100.0% |
2010 Q2 | 358.24 Million JPY | 17.13% |
2010 Q4 | 602 Million JPY | 4.88% |
2010 Q3 | 574.02 Million JPY | 60.23% |
2010 FY | 1.52 Billion JPY | 6.14% |
2010 Q1 | 305.84 Million JPY | -16.63% |
2009 Q4 | 366.86 Million JPY | -26.26% |
2009 FY | 1.44 Billion JPY | 24.81% |
2009 Q3 | 497.48 Million JPY | 14.11% |
2009 Q2 | 435.95 Million JPY | 42.17% |
2009 Q1 | 306.64 Million JPY | 5.15% |
2008 Q4 | 291.61 Million JPY | -28.14% |
2008 FY | 1.15 Billion JPY | 0.0% |
2008 Q3 | 405.81 Million JPY | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
HEARTSEED INC | -1.45 Billion JPY | 362.535% |
Cawachi Limited | 7.6 Billion JPY | 49.586% |
Pharmarise Holdings Corporation | 916 Million JPY | -318.341% |
Qol Holdings Co., Ltd. | 8.32 Billion JPY | 53.97% |
MatsukiyoCocokara & Co. | 75.7 Billion JPY | 94.938% |
Welcia Holdings Co., Ltd. | 43.23 Billion JPY | 91.136% |
Create SD Holdings Co., Ltd. | 20.22 Billion JPY | 81.055% |
NIHON CHOUZAI Co.,Ltd. | 9.14 Billion JPY | 58.093% |
COSMOS Pharmaceutical Corporation | 31.5 Billion JPY | 87.835% |
Tsuruha Holdings Inc. | 49.2 Billion JPY | 92.212% |
Ohki Healthcare Holdings Co.,Ltd. | 2.04 Billion JPY | -87.476% |
Satudora Holdings Co.,Ltd. | 1.38 Billion JPY | -176.679% |
Kusuri No Aoki Holdings Co., Ltd. | 18.56 Billion JPY | 79.363% |
Shinnihonseiyaku Co., Ltd. | 3.75 Billion JPY | -2.078% |
Sugi Holdings Co.,Ltd. | 36.62 Billion JPY | 89.537% |
YAKUODO HOLDINGS Co., Ltd. | 5.21 Billion JPY | 26.463% |
Astena Holdings Co., Ltd. | 1.12 Billion JPY | -239.688% |
Genky DrugStores Co., Ltd. | 9.01 Billion JPY | 57.498% |
Ain Holdings Inc. | 20.43 Billion JPY | 81.245% |
Sundrug Co.,Ltd. | 40.99 Billion JPY | 90.653% |